• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Transfusion Related Acute Lung Injury (TRALI)

Audience: Health Professionals, particularly Respiratory Specialists

FDA alerts health professionals to the risk of Transfusion Related Acute Lung Injury (TRALI) in patients who receive blood products, particularly plasma-containing products. TRALI is a serious pulmonary syndrome that can lead to death if not recognized and treated appropriately. Recognition of symptoms and immediate treatment are imperative.

[October 19, 2001 - Letter - FDA]